QQ客服 官方微博 反馈留言

	Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer
	Lu, S; Chang, JH; Liu, XQ; Shi, JH; Lu, Y; Li, W; Yang, JJ; Zhou, JY; Wang, J; An, TT
刊名	JOURNAL OF CLINICAL ONCOLOGY
	2018
卷号	Vol.36 No.12页码:1207
ISSN号	0732-183X
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1842563
专题	四川大学
作者单位	1.Shanghai Jiao Tong Univ, Shanghai, Peoples R China 2.Chinese Peoples Liberat Army, Hosp 307, Beijing, Peoples R China 3.Beijing Canc Hosp, Beijing, Peoples R China 4.Southwest Hosp, Chongqing, Peoples R China 5.Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China 6.Sichuan Univ, Chengdu, Sichuan, Peoples R China 7.Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China 8.Nantong Tumor Hosp, Nantong, Peoples R China 9.Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China 10.Linyi Canc Hosp, Linyi, Peoples R China
推荐引用方式 GB/T 7714	Lu, S,Chang, JH,Liu, XQ,et al. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer[J]. JOURNAL OF CLINICAL ONCOLOGY,2018,Vol.36 No.12:1207.
APA	Lu, S.,Chang, JH.,Liu, XQ.,Shi, JH.,Lu, Y.,...&An, TT.(2018).Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer.JOURNAL OF CLINICAL ONCOLOGY,Vol.36 No.12,1207.
MLA	Lu, S,et al."Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer".JOURNAL OF CLINICAL ONCOLOGY Vol.36 No.12(2018):1207.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。